Baidu
map

泻药可能增加患癌风险

2018-01-25 佚名 新华社

欧盟食品安全局 1 月 23 日警告说,长期服用番泻叶、大黄等植物提取物制成的泻药,可能会带来一些潜在健康问题,如增加罹患癌症的风险等。

欧盟食品安全局 1 月 23 日警告说,长期服用番泻叶、大黄等植物提取物制成的泻药,可能会带来一些潜在健康问题,如增加罹患癌症的风险等。

泻药通常包含羟基蒽类衍生物,这类化合物常见于番泻叶、大黄等植物的根、叶子、种子和树皮等部位。

欧盟食品安全局在一份声明中说,一些羟基蒽类衍生物可能会造成 DNA(脱氧核糖核酸)损伤。动物实验表明,摄入这类物质可能会导致肠癌。

欧盟食品安全局表示,目前尚无法就此设定一个安全的每日摄入量限值,但是重申此前不要长期高剂量服用这类物质的建议。欧盟食品安全局曾于 2013 年表示,食品中的羟基蒽类衍生物或可改善肠道功能,但建议不要长期过量服用。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2061707, encodeId=22992061e07f7, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Mon Jun 04 16:26:00 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285072, encodeId=3dd22850e29e, content=学习了.以后用药用小心, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iatia2cT76F0wiceqgFicEXqwC1iaC4mwmVOR9onEYJ9mHKVUHx8tqoPbJiakAIzgut3SdoQspXkbPY9FiabzE14IusDA/132, createdBy=60641826220, createdName=huizi3382, createdTime=Sun Feb 04 15:22:56 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413464, encodeId=8a8a141346407, content=<a href='/topic/show?id=3f225299942' target=_blank style='color:#2F92EE;'>#患癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52999, encryptionId=3f225299942, topicName=患癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b2c2959841, createdName=zzc2212, createdTime=Sat Jan 27 05:26:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489399, encodeId=01b41489399ce, content=<a href='/topic/show?id=6647650e22d' target=_blank style='color:#2F92EE;'>#泻药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65072, encryptionId=6647650e22d, topicName=泻药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ddee8545068, createdName=xuqianhua, createdTime=Sat Jan 27 05:26:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601432, encodeId=8a12160143293, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Jan 27 05:26:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=281915, encodeId=bd97281915be, content=学习了.注意用药风险., beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Thu Jan 25 16:13:16 CST 2018, time=2018-01-25, status=1, ipAttribution=)]
    2018-06-04 sjq027
  2. [GetPortalCommentsPageByObjectIdResponse(id=2061707, encodeId=22992061e07f7, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Mon Jun 04 16:26:00 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285072, encodeId=3dd22850e29e, content=学习了.以后用药用小心, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iatia2cT76F0wiceqgFicEXqwC1iaC4mwmVOR9onEYJ9mHKVUHx8tqoPbJiakAIzgut3SdoQspXkbPY9FiabzE14IusDA/132, createdBy=60641826220, createdName=huizi3382, createdTime=Sun Feb 04 15:22:56 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413464, encodeId=8a8a141346407, content=<a href='/topic/show?id=3f225299942' target=_blank style='color:#2F92EE;'>#患癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52999, encryptionId=3f225299942, topicName=患癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b2c2959841, createdName=zzc2212, createdTime=Sat Jan 27 05:26:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489399, encodeId=01b41489399ce, content=<a href='/topic/show?id=6647650e22d' target=_blank style='color:#2F92EE;'>#泻药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65072, encryptionId=6647650e22d, topicName=泻药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ddee8545068, createdName=xuqianhua, createdTime=Sat Jan 27 05:26:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601432, encodeId=8a12160143293, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Jan 27 05:26:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=281915, encodeId=bd97281915be, content=学习了.注意用药风险., beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Thu Jan 25 16:13:16 CST 2018, time=2018-01-25, status=1, ipAttribution=)]
    2018-02-04 huizi3382

    学习了.以后用药用小心

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2061707, encodeId=22992061e07f7, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Mon Jun 04 16:26:00 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285072, encodeId=3dd22850e29e, content=学习了.以后用药用小心, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iatia2cT76F0wiceqgFicEXqwC1iaC4mwmVOR9onEYJ9mHKVUHx8tqoPbJiakAIzgut3SdoQspXkbPY9FiabzE14IusDA/132, createdBy=60641826220, createdName=huizi3382, createdTime=Sun Feb 04 15:22:56 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413464, encodeId=8a8a141346407, content=<a href='/topic/show?id=3f225299942' target=_blank style='color:#2F92EE;'>#患癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52999, encryptionId=3f225299942, topicName=患癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b2c2959841, createdName=zzc2212, createdTime=Sat Jan 27 05:26:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489399, encodeId=01b41489399ce, content=<a href='/topic/show?id=6647650e22d' target=_blank style='color:#2F92EE;'>#泻药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65072, encryptionId=6647650e22d, topicName=泻药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ddee8545068, createdName=xuqianhua, createdTime=Sat Jan 27 05:26:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601432, encodeId=8a12160143293, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Jan 27 05:26:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=281915, encodeId=bd97281915be, content=学习了.注意用药风险., beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Thu Jan 25 16:13:16 CST 2018, time=2018-01-25, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2061707, encodeId=22992061e07f7, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Mon Jun 04 16:26:00 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285072, encodeId=3dd22850e29e, content=学习了.以后用药用小心, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iatia2cT76F0wiceqgFicEXqwC1iaC4mwmVOR9onEYJ9mHKVUHx8tqoPbJiakAIzgut3SdoQspXkbPY9FiabzE14IusDA/132, createdBy=60641826220, createdName=huizi3382, createdTime=Sun Feb 04 15:22:56 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413464, encodeId=8a8a141346407, content=<a href='/topic/show?id=3f225299942' target=_blank style='color:#2F92EE;'>#患癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52999, encryptionId=3f225299942, topicName=患癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b2c2959841, createdName=zzc2212, createdTime=Sat Jan 27 05:26:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489399, encodeId=01b41489399ce, content=<a href='/topic/show?id=6647650e22d' target=_blank style='color:#2F92EE;'>#泻药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65072, encryptionId=6647650e22d, topicName=泻药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ddee8545068, createdName=xuqianhua, createdTime=Sat Jan 27 05:26:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601432, encodeId=8a12160143293, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Jan 27 05:26:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=281915, encodeId=bd97281915be, content=学习了.注意用药风险., beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Thu Jan 25 16:13:16 CST 2018, time=2018-01-25, status=1, ipAttribution=)]
    2018-01-27 xuqianhua
  5. [GetPortalCommentsPageByObjectIdResponse(id=2061707, encodeId=22992061e07f7, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Mon Jun 04 16:26:00 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285072, encodeId=3dd22850e29e, content=学习了.以后用药用小心, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iatia2cT76F0wiceqgFicEXqwC1iaC4mwmVOR9onEYJ9mHKVUHx8tqoPbJiakAIzgut3SdoQspXkbPY9FiabzE14IusDA/132, createdBy=60641826220, createdName=huizi3382, createdTime=Sun Feb 04 15:22:56 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413464, encodeId=8a8a141346407, content=<a href='/topic/show?id=3f225299942' target=_blank style='color:#2F92EE;'>#患癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52999, encryptionId=3f225299942, topicName=患癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b2c2959841, createdName=zzc2212, createdTime=Sat Jan 27 05:26:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489399, encodeId=01b41489399ce, content=<a href='/topic/show?id=6647650e22d' target=_blank style='color:#2F92EE;'>#泻药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65072, encryptionId=6647650e22d, topicName=泻药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ddee8545068, createdName=xuqianhua, createdTime=Sat Jan 27 05:26:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601432, encodeId=8a12160143293, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Jan 27 05:26:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=281915, encodeId=bd97281915be, content=学习了.注意用药风险., beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Thu Jan 25 16:13:16 CST 2018, time=2018-01-25, status=1, ipAttribution=)]
    2018-01-27 zhouqu_8
  6. [GetPortalCommentsPageByObjectIdResponse(id=2061707, encodeId=22992061e07f7, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Mon Jun 04 16:26:00 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285072, encodeId=3dd22850e29e, content=学习了.以后用药用小心, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iatia2cT76F0wiceqgFicEXqwC1iaC4mwmVOR9onEYJ9mHKVUHx8tqoPbJiakAIzgut3SdoQspXkbPY9FiabzE14IusDA/132, createdBy=60641826220, createdName=huizi3382, createdTime=Sun Feb 04 15:22:56 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413464, encodeId=8a8a141346407, content=<a href='/topic/show?id=3f225299942' target=_blank style='color:#2F92EE;'>#患癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52999, encryptionId=3f225299942, topicName=患癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b2c2959841, createdName=zzc2212, createdTime=Sat Jan 27 05:26:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489399, encodeId=01b41489399ce, content=<a href='/topic/show?id=6647650e22d' target=_blank style='color:#2F92EE;'>#泻药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65072, encryptionId=6647650e22d, topicName=泻药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ddee8545068, createdName=xuqianhua, createdTime=Sat Jan 27 05:26:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601432, encodeId=8a12160143293, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Jan 27 05:26:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=281915, encodeId=bd97281915be, content=学习了.注意用药风险., beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Thu Jan 25 16:13:16 CST 2018, time=2018-01-25, status=1, ipAttribution=)]
    2018-01-25 1e0f8808m18(暂无匿称)

    学习了.注意用药风险.

    0

相关资讯

Gut:肠道准备时,分次使用肠道清洁剂VS一次性使用

结肠镜检查效果好坏很大程度上受到了肠道准备的影响,肠道干净,看的自然清楚。临场上对患者的肠道准备通常是泻药+灌肠。泻药对患者是安全的,不过这些肠道准备会对肠道菌群造成什么样的影响呢?尤其是长期的影响,目前是不清楚的。研究者将23名健康人群随机分为2组进行肠道准备,使用Moviprep,一种肠道清洁剂。一组每次使用1L,共2次,另一组一次性使用2L。参与者分别在纳入研究时、清洁肠道后、治疗后14和2

Colorectal Dis:骶神经调节用于青少年慢性便秘

慢性便秘严重影响儿童和青少年的生活质量,初步证据表明骶神经调节可改善顽固性功能性便秘患者的症状和生活质量,同时花费较为合理

Baidu
map
Baidu
map
Baidu
map